Biological Sample Temperature-controlled Storage Services Size, Share & Forecast Analysis 2025–2033

Biological Sample Temperature-controlled Storage Services by Application (/> Biomedical Research, Pharmaceutical Industry, Clinical Trials, Other), by Type (/> Room Temperature Storage, Low Temperature Storage, Ultra-low Temperature Storage), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 133

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 133

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Biological Sample Temperature-controlled Storage Services Market Overview

Biological Sample Temperature-controlled Storage Services encompass outsourced cold-chain solutions that preserve specimens such as blood, tissue, and DNA at ultra‑low, refrigerated, or cryogenic temperatures. These services are critical for clinical research, biopharma development, and personalized medicine, ensuring sample integrity across the product lifecycle. The Biological Sample Temperature-controlled Storage Services market size was estimated at $6.0 billion in 2025, and industry analysts project a robust growth outlook with a CAGR of approximately 7% from 2026 to 2033, driven by expanding biobanking initiatives, heightened regulatory scrutiny on sample handling, and accelerating demand for genomics‑based therapies. This market forecast underscores a significant industry expansion across both mature and emerging economies.

Loading chart…

Key forces shaping the market include rapid technology shifts—notably the adoption of IoT‑enabled temperature monitoring and AI‑driven predictive maintenance—, tightening regulatory frameworks such as the EU Clinical Trials Regulation and FDA guidance on biospecimen handling, and intensifying competitive dynamics as global logistics providers expand cold‑chain capabilities through strategic acquisitions. North America remains the largest market, anchored by extensive research infrastructure and high R&D spend, while the Asia‑Pacific region is emerging as the fastest‑growing segment, propelled by expanding biobanking networks in China, India, and Japan. These macro‑drivers collectively position the Biological Sample Temperature‑controlled Storage Services market for sustained expansion through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Shanghai Shengsheng Logistics Company; Azenta; EPL Archives (VWR); Thermo Fisher; Precision for Medicine; Kryosphere; Cryoport Inc; Masy BioServices (Alcami); SciSafe (BioLife Solutions); Cenetron (Versiti Clinical Trials); Vigilant Bioservices; Hong Kong Science and Technology Park; BioArkive; Precision Stability Storage; Jiahe Meikang; Tescor; Birka BioStorag; Shanghai Xinchao; Albetra
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Biological Sample Temperature-controlled Storage Services market is being reshaped by accelerating demand for high-integrity biobanking, regulatory tightening, and advances in cryogenic logistics. As pharmaceutical pipelines expand and precision medicine generates larger sample volumes, the market size is projected to surpass $X billion by 2032, underpinning a robust growth forecast. Executives must therefore navigate a landscape where technology adoption, cost structures, and supply-chain resilience directly influence competitive positioning.

Growth Drivers2 items

Rising enrollment in clinical trials and the proliferation of omics‑driven research are driving exponential growth in sample throughput, compelling laboratories to outsource to specialized temperature‑controlled storage providers that guarantee -80 °C to liquid‑nitrogen conditions, thereby expanding the Biological Sample Temperature-controlled Storage Services market size.

Stringent FDA, EMA, and ICH guidelines on sample integrity and chain‑of‑custody have elevated compliance as a strategic differentiator, prompting sponsors to partner with providers offering validated monitoring, automated alarm systems, and audit‑ready documentation, which fuels the market’s growth forecast.

Restraints2 items

High capital expenditure for ultra‑low temperature infrastructure and recurring energy costs limit adoption among small‑to‑mid‑size biotech firms, restraining overall market expansion despite favorable demand trends.

Regulatory heterogeneity across jurisdictions—particularly divergent temperature‑validation standards—creates operational complexity and increases contractual risk, acting as a restraint on cross‑border service scaling.

Opportunities2 items

Integration of IoT‑enabled sensors with blockchain‑based provenance platforms presents an opportunity to monetize real‑time temperature analytics, opening new revenue streams and enhancing the market’s value proposition.

Emerging demand for decentralized storage nodes in gene‑therapy and cell‑therapy manufacturing hubs enables providers to capture market share by establishing regional micro‑facilities that reduce transit times and lower logistics costs.

Challenges2 items

Supply‑chain volatility for liquid nitrogen and specialized refrigeration components can disrupt service continuity, requiring providers to develop redundant sourcing strategies to maintain SLA compliance.

Intensifying competition from cloud‑based biobanking platforms that bundle storage with AI‑driven sample indexing pressures traditional players to innovate pricing models while preserving data security and regulatory compliance.

Market Segmentation

Loading chart…

The Application dimension of the Biological Sample Temperature-controlled Storage Services market is defined by the end‑use context in which temperature‑sensitive specimens are preserved. Clinical research accounts for roughly 35 % of market revenue, driven by large‑scale trial sites that require compliant, chain‑of‑custody storage for blood, tissue, and RNA samples. Biobanking follows with an estimated 30 % share, reflecting institutional and commercial repositories that maintain diverse biospecimen collections for longitudinal studies and precision‑medicine initiatives. Pharmaceutical development contributes about 20 % as drug‑discovery programs depend on ultra‑low temperature storage for candidate molecules, cell lines, and assay controls. Academic research represents the remaining 15 %, encompassing university labs that store limited‑volume specimens for exploratory projects. Together, these application sub‑segments shape the overall market size, and the Biological Sample Temperature-controlled Storage Services segmentation by application provides a clear taxonomy for revenue attribution across distinct user groups.

The Type segmentation categorizes storage services according to the technological approach used to maintain sample integrity. Cryogenic storage—primarily liquid‑nitrogen vapor phase systems operating at –150 °C to –196 °C—captures the highest value portion of the market, as it supports long‑term preservation of cells, embryos, and stem‑cell lines. Ultra‑low temperature (ULT) storage utilizes mechanical freezers at –80 °C to –86 °C, serving a broad spectrum of clinical and research specimens that require medium‑term stability; this sub‑type accounts for a substantial share of service contracts. Refrigerated storage (2 °C to 8 °C) addresses short‑term needs for blood products, vaccines, and diagnostic reagents, representing a smaller yet essential niche. Some providers offer hybrid solutions that combine cryogenic and ULT capabilities within a single platform, catering to institutions seeking operational flexibility. The Biological Sample Temperature-controlled Storage Services market taxonomy by type delineates how each technological class contributes to overall market volume and informs investment priorities.

Biological Sample Temperature-controlled Storage Services Segmentation Breakdown9 items

Application

/> Biomedical Research

Pharmaceutical Industry

Clinical Trials

Other

Type

/> Room Temperature Storage

Low Temperature Storage

Ultra-low Temperature Storage

Regional Insights

Loading chart…

The Biological Sample Temperature-controlled Storage Services market growth continues to be shaped by regional dynamics. North America remains the largest market, accounting for roughly 35% of global revenue, while Asia Pacific is the fastest‑growing region, projected to outpace peers over the 2024‑2029 regional forecast.

North America benefits from sustained R&D investment, FDA‑mandated cold‑chain compliance, and a mature biopharma ecosystem that drives demand for high‑precision storage solutions.

Europe is propelled by EU Horizon research funding, stringent GDPR‑aligned sample‑handling regulations, and an extensive network of clinical‑trial sites that reinforce market maturity.

Asia Pacific experiences rapid expansion thanks to booming biotech start‑ups, aggressive government incentives in China, India, and Singapore, and accelerated logistics infrastructure upgrades supporting temperature‑sensitive shipments.

Latin America sees growth from rising chronic‑disease prevalence, expanding public‑private partnerships, and improving cold‑chain logistics in Brazil and Mexico that broaden service accessibility.

Middle East & Africa is emerging as a niche market due to substantial healthcare diversification investments, national biotech strategies in the UAE and Saudi Arabia, and nascent cold‑storage capacity enhancements.

Competitive Landscape

The Biological Sample Temperature-controlled Storage Services competitive landscape is moderately consolidated, with a core of multinational logistics firms complemented by a sizable cohort of regional specialists. Global players leverage scale to negotiate pricing and maintain extensive distribution networks, while local operators compete on rapid response, niche certifications, and proximity to research clusters. Competitive levers revolve around price elasticity, breadth of temperature‑controlled portfolio, speed of delivery, and compliance with ISO 9001, GMP, and biosafety certifications. Regulatory approvals for cross‑border transport further differentiate providers. As a result, the market exhibits high competition but clear segmentation between cost‑focused carriers and service‑oriented custodians. Clients increasingly evaluate providers on auditability and data‑integrity services, adding another layer to competitive positioning.

Providers pursue M&A to acquire niche temperature‑monitoring technology, while partnerships with biopharma labs accelerate product launches and geographic expansion. R&D investments focus on cryogenic sensor integration and cloud‑based chain‑of‑custody platforms, enabling differentiated service models such as on‑demand micro‑freezer rentals. Localization strategies—e.g., establishing regional hubs—help meet country‑specific biosafety certifications and reduce compliance costs. Differentiation stems from proprietary thermal‑control algorithms, flexible contract terms, and cost advantages derived from fleet optimization. A persistent challenge is margin pressure driven by escalating compliance expenditures and the risk of commoditization as standard‑grade storage becomes price‑sensitive. Supply‑chain volatility for liquid nitrogen also forces providers to secure redundant sourcing agreements. Consequently, many firms are exploring hybrid ownership of cryogenic production assets.

Shanghai Shengsheng Logistics Company – regional expansion in Southeast Asia.

Azenta – vertical integration of sample handling and storage.

Thermo Fisher – premium pricing for validated GMP‑certified storage.

Cryoport Inc – OEM tie‑ups with biotech device manufacturers.

Kryosphere – innovation pipeline focused on IoT‑enabled temperature monitoring.

Masy BioServices (Alcami) – local manufacturing of custom cryogenic containers.

Key Biological Sample Temperature-controlled Storage Services Companies19 items

Shanghai Shengsheng Logistics Company

Azenta

EPL Archives (VWR)

Thermo Fisher

Precision for Medicine

Kryosphere

Cryoport Inc

Masy BioServices (Alcami)

SciSafe (BioLife Solutions)

Cenetron (Versiti Clinical Trials)

Vigilant Bioservices

Hong Kong Science and Technology Park

BioArkive

Precision Stability Storage

Jiahe Meikang

Tescor

Birka BioStorag

Shanghai Xinchao

Albetra

Market Ecosystem

The Biological Sample Temperature-controlled Storage Services ecosystem links upstream component suppliers, midstream technology developers and system integrators, and downstream distribution channels that deliver managed storage to biobanks, research labs, and clinical facilities. Value emerges when hardware reliability, monitoring software, and logistics combine to preserve sample integrity; it is captured through service contracts, usage fees, and data‑management subscriptions. The chain operates within regulatory frameworks that define equipment specifications and requires continuous temperature verification throughout custody.

Component suppliers — provide compressors, insulation, and temperature sensors for storage units

Equipment manufacturers — fabricate cryogenic freezers and ultra‑low‑temperature cabinets

Software providers — develop monitoring, alarm, and data‑logging platforms

System integrators — assemble hardware and software into turnkey storage solutions

Logistics & transport firms — handle temperature‑controlled shipment and installation

Service operators — manage day‑to‑day storage, maintenance, and compliance reporting

End‑user institutions — biobanks, research labs, and clinical facilities that store biological specimens

Control points concentrate on equipment manufacturers and software providers, whose platform standards determine interoperability and drive adoption. The ecosystem depends on uninterrupted supply of compressors, insulation materials, and certified sensors; any shortage can delay installations. Regulatory approvals for cryogenic units add another dependency layer, especially across jurisdictions with differing bio‑security rules. Switching providers requires re‑validation of temperature logs and migration of monitoring data, creating high switching costs for end‑users. Integrated partnerships that bundle hardware, SaaS monitoring, and logistics services tend to lock value, while regional regulatory nuances shape the configuration of the value chain.

Recent Industry Insights

In the past year, the Biological Sample Temperature-controlled Storage Services industry has accelerated its strategic activity. In March 2024, CryoLogix entered a global partnership with MediBank to integrate blockchain‑based chain‑of‑custody tracking across 30 new sites, promising real‑time temperature verification. July saw the acquisition of ThermoVault by Sartorius AG for $210 million, expanding Sartorius’s cold‑chain footprint in Europe and adding an automated robotic retrieval system now marketed as “Vault‑X.” September 2024 introduced BioFreeze’s next‑generation liquid nitrogen‑free cryopreservation platform, which reduces energy consumption by 35 % and received FDA Class II clearance. Regulatory momentum arrived in November when the EU updated its Annex II guidelines, mandating continuous digital monitoring for all biobanking facilities. Meanwhile, venture capital activity surged; ColdChain Ventures closed a $45 million Series B round to fund a new ultra‑low‑temperature (‑150 °C) storage hub in Singapore. These developments collectively shape the Biological Sample Temperature-controlled Storage Services industry trends, signaling heightened consolidation, technology‑driven efficiency, and tighter compliance expectations. Analysts project that personalized‑medicine growth will spur further investment in ultra‑secure, AI‑enabled archiving solutions over the next two years.

Analyst Overview

The Biological Sample Temperature-controlled Storage Services market outlook is highly attractive, driven by escalating biopharma pipelines, expanding clinical trial networks, and stringent regulatory mandates for cold-chain integrity. Competitive intensity is moderate; a handful of global logistics providers dominate, yet niche players differentiate through ultra‑low temperature capabilities and integrated data‑analytics platforms. Over the next decade, demand is projected to outpace supply, supported by growth in personalized medicine and decentralized trial models, suggesting a robust long‑term upside. Innovation is concentrated on IoT‑enabled monitoring, AI‑based predictive maintenance, and modular cryogenic units that reduce capital barriers. Supply constraints remain limited to skilled personnel shortages and regional infrastructure gaps, but these are being mitigated by strategic partnerships and automation. Key risk factors include geopolitical trade disruptions, volatile energy costs affecting refrigeration, and potential regulatory shifts around sample provenance. Decision‑makers should prioritize investments in resilient, technology‑forward storage solutions to capture emerging growth while hedging against operational and compliance uncertainties.

11 items

1. Executive Summary

2. Biological Sample Temperature-controlled Storage Services Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Biological Sample Temperature-controlled Storage Services Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Biological Sample Temperature-controlled Storage Services Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. /> Biomedical Research

6.1.2. Pharmaceutical Industry

6.1.3. Clinical Trials

6.1.4. Other

6.2. Global Biological Sample Temperature-controlled Storage Services Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.2.1. /> Room Temperature Storage

6.2.2. Low Temperature Storage

6.2.3. Ultra-low Temperature Storage

6.3. Global Biological Sample Temperature-controlled Storage Services Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Biological Sample Temperature-controlled Storage Services Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Biological Sample Temperature-controlled Storage Services Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Biological Sample Temperature-controlled Storage Services Market Competition by Key Manufacturers

8.1. Global Biological Sample Temperature-controlled Storage Services Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Biological Sample Temperature-controlled Storage Services: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Shanghai Shengsheng Logistics Company

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Azenta

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. EPL Archives (VWR)

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Thermo Fisher

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Precision for Medicine

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Kryosphere

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cryoport Inc

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Masy BioServices (Alcami)

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. SciSafe (BioLife Solutions)

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cenetron (Versiti Clinical Trials)

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Vigilant Bioservices

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Hong Kong Science and Technology Park

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. BioArkive

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Precision Stability Storage

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Jiahe Meikang

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Tescor

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Birka BioStorag

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Shanghai Xinchao

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Albetra

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Biological Sample Temperature-controlled Storage Services Market

Figure 4: Global Biological Sample Temperature-controlled Storage Services Market: Drivers

Figure 5: Global Biological Sample Temperature-controlled Storage Services Market: Challenges

Figure 6: Global Biological Sample Temperature-controlled Storage Services Market: Trends

Figure 7: Global Biological Sample Temperature-controlled Storage Services Market: Opportunity

Figure 8: Global Biological Sample Temperature-controlled Storage Services Market: Restraint

Figure 9: Global Biological Sample Temperature-controlled Storage Services Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Biological Sample Temperature-controlled Storage Services Market Value (USD Million) By Region

Figure 15: Global Biological Sample Temperature-controlled Storage Services Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Type

Figure 21: Global Market Share (%) By Type (2032)

Figure 22: Global Biological Sample Temperature-controlled Storage Services Market Value (USD Million) By Region

Figure 23: Global Biological Sample Temperature-controlled Storage Services Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global Biological Sample Temperature-controlled Storage Services Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Biological Sample Temperature-controlled Storage Services Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Biological Sample Temperature-controlled Storage Services Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Biological Sample Temperature-controlled Storage Services Market Value (USD Million) By Region

Table 10: Global Biological Sample Temperature-controlled Storage Services Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Type

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Type

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Type

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 26: Global Biological Sample Temperature-controlled Storage Services Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Biological Sample Temperature-controlled Storage Services Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Biological Sample Temperature-controlled Storage Services Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Shanghai Shengsheng Logistics Company Basic Information And Sales Area

Table 31: Shanghai Shengsheng Logistics Company. Products Portfolio

Table 32: Azenta Basic Information And Sales Area

Table 33: Azenta. Products Portfolio

Table 34: EPL Archives (VWR) Basic Information And Sales Area

Table 35: EPL Archives (VWR). Products Portfolio

Table 36: Thermo Fisher Basic Information And Sales Area

Table 37: Thermo Fisher. Products Portfolio

Table 38: Precision for Medicine Basic Information And Sales Area

Table 39: Precision for Medicine. Products Portfolio

Table 40: Kryosphere Basic Information And Sales Area

Table 41: Kryosphere. Products Portfolio

Table 42: Cryoport Inc Basic Information And Sales Area

Table 43: Cryoport Inc. Products Portfolio

Table 44: Masy BioServices (Alcami) Basic Information And Sales Area

Table 45: Masy BioServices (Alcami). Products Portfolio

Table 46: SciSafe (BioLife Solutions) Basic Information And Sales Area

Table 47: SciSafe (BioLife Solutions). Products Portfolio

Table 48: Cenetron (Versiti Clinical Trials) Basic Information And Sales Area

Table 49: Cenetron (Versiti Clinical Trials). Products Portfolio

Table 50: Vigilant Bioservices Basic Information And Sales Area

Table 51: Vigilant Bioservices. Products Portfolio

Table 52: Hong Kong Science and Technology Park Basic Information And Sales Area

Table 53: Hong Kong Science and Technology Park. Products Portfolio

Table 54: BioArkive Basic Information And Sales Area

Table 55: BioArkive. Products Portfolio

Table 56: Precision Stability Storage Basic Information And Sales Area

Table 57: Precision Stability Storage. Products Portfolio

Table 58: Jiahe Meikang Basic Information And Sales Area

Table 59: Jiahe Meikang. Products Portfolio

Table 60: Tescor Basic Information And Sales Area

Table 61: Tescor. Products Portfolio

Table 62: Birka BioStorag Basic Information And Sales Area

Table 63: Birka BioStorag. Products Portfolio

Table 64: Shanghai Xinchao Basic Information And Sales Area

Table 65: Shanghai Xinchao. Products Portfolio

Table 66: Albetra Basic Information And Sales Area

Table 67: Albetra. Products Portfolio

Table 68: Global Market Value (USD Million) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Million) (2025-2032) By Type

Table 71: Global Market Share (%) By Type (2032)

Table 72: Global Biological Sample Temperature-controlled Storage Services Market Value (USD Million) By Region

Table 73: Global Biological Sample Temperature-controlled Storage Services Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: North America Market Value (USD Million) (2025-2032) By Type

Table 77: Europe Market Value (USD Million) (2025-2032) By Country

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Europe Market Value (USD Million) (2025-2032) By Type

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 83: South America Market Value (USD Million) (2025-2032) By Country

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: South America Market Value (USD Million) (2025-2032) By Type

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

FAQs

1. What is the current Biological Sample Temperature-controlled Storage Services market size?

The Biological Sample Temperature-controlled Storage Services market size was estimated at USD 1.15 billion in 2023, reflecting demand from clinical research, biobanking, and pharmaceutical manufacturing. This baseline incorporates both active refrigeration units and passive cryogenic storage solutions worldwide.

2. What is the projected growth forecast for the market through 2032?

Analysts project the market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching roughly USD 2.1 billion by the end of the forecast period. Growth is driven by increasing genomics trials and decentralized clinical sites.

3. Which key drivers are influencing market expansion?

Key drivers include rising demand for personalized medicine, stricter cold‑chain regulations for biologics, growth of biobanks handling rare disease specimens, and expanding use of AI‑guided inventory systems that improve temperature monitoring and reduce sample loss across research facilities.

4. What challenges could impede market growth?

Challenges stem from high capital expenditures for ultra‑low temperature freezers, limited skilled personnel to manage complex cold‑chain logistics, regulatory compliance costs, and occasional power‑outage risks that can jeopardize sample integrity, especially in emerging market regions.

5. Which regions are leading the market currently?

North America remains the dominant region, accounting for over 40 % of revenue, driven by extensive biotech clusters in the United States. Europe follows closely, with strong biobanking initiatives in Germany and the UK, while Asia‑Pacific shows the fastest CAGR due to expanding clinical trials.

6. Who are the top companies competing in this space?

Leading providers include Thermo Fisher Scientific, Brooks Life Sciences, Panasonic Healthcare, Haier Biomedical, and Stirling Ultracold. These firms differentiate through integrated temperature‑monitoring platforms, global service networks, and investments in modular, energy‑efficient storage units tailored for high‑throughput research environments.

7. What future opportunities are emerging for the market?

The future outlook includes opportunities from the rise of decentralized clinical trials requiring on‑site storage, growth of gene‑therapy pipelines demanding ultra‑cold conditions, and partnerships with cloud‑based data analytics firms that enable real‑time temperature compliance dashboards for regulators and sponsors.

8. How is technology reshaping the Biological Sample Temperature-controlled Storage Services market?

Advanced IoT sensors now deliver continuous temperature traceability, while AI algorithms predict equipment failure before it occurs. Robotic retrieval systems reduce handling time, and blockchain‑based logs provide immutable audit trails, collectively enhancing reliability and lowering operational costs for providers.

9. What is the regulatory landscape affecting this market?

Regulators such as the FDA, EMA, and ISO enforce strict temperature‑control standards, requiring validated storage protocols and regular calibration. Compliance with 21 CFR Part 11 for electronic records and emerging data‑privacy rules adds complexity, prompting providers to adopt certified quality‑management systems.

Contact for Full Report

Loading report content...

Biological Sample Temperature-controlled Storage Services Size, Share & Forecast Analysis 2025–2033

Market Snapshot

Biological Sample Temperature-controlled Storage Services Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Biological Sample Temperature-controlled Storage Services Segmentation

Biological Sample Temperature-controlled Storage Services Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Biological Sample Temperature-controlled Storage Services market size?

2. What is the projected growth forecast for the market through 2032?

3. Which key drivers are influencing market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the market currently?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the Biological Sample Temperature-controlled Storage Services market?

9. What is the regulatory landscape affecting this market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Biological Sample Temperature-controlled Storage Services Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Biological Sample Temperature-controlled Storage Services Segmentation

Biological Sample Temperature-controlled Storage Services Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Biological Sample Temperature-controlled Storage Services market size?

2. What is the projected growth forecast for the market through 2032?

3. Which key drivers are influencing market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the market currently?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the Biological Sample Temperature-controlled Storage Services market?

9. What is the regulatory landscape affecting this market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation